Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma.
about
Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Phase 1/2 study of weekly carf ...... transplant-ineligible myeloma.
@en
Phase 1/2 study of weekly carf ...... transplant-ineligible myeloma.
@nl
type
label
Phase 1/2 study of weekly carf ...... transplant-ineligible myeloma.
@en
Phase 1/2 study of weekly carf ...... transplant-ineligible myeloma.
@nl
prefLabel
Phase 1/2 study of weekly carf ...... transplant-ineligible myeloma.
@en
Phase 1/2 study of weekly carf ...... transplant-ineligible myeloma.
@nl
P2093
P2860
P50
P356
P1433
P1476
Phase 1/2 study of weekly carf ...... transplant-ineligible myeloma
@en
P2093
A M Liberati
C De Angelis
L De Paoli
M Boccadoro
M D'Agostino
M Offidani
M T Petrucci
P2860
P2888
P304
P356
10.1038/LEU.2017.327
P577
2017-11-16T00:00:00Z